Capsule Reviews

» birds and disease/medicine

Most Recent

image: Capsule Reviews

Capsule Reviews

By | September 1, 2015

Brain Storms, Orphan, Maize for the Gods, and Paranoid.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | March 1, 2015

Evolving Ourselves, The Man Who Touched His Own Heart, Bats, and The Invaders

1 Comment

image: Capsule Reviews

Capsule Reviews

By | July 1, 2014

Sex on Earth, Wild Connection, The Classification of Sex, and XL Love

0 Comments

image: Capsule Reviews

Capsule Reviews

By | May 1, 2014

Madness and Memory, Promoting the Planck Club, The Carnivore Way, and The Tale of the Dueling Neurosurgeons

0 Comments

image: Capsule Reviews

Capsule Reviews

By | December 1, 2012

Unusual Creatures, Extinct Boids, The Mating Lives of Birds and A World in One Cubic Foot

0 Comments

image: Capsule Reviews

Capsule Reviews

By | August 1, 2012

Gifts of the Crow, What the Robin Knows, The Unfeathered Bird, and America’s Other Audubon

0 Comments

image: Capsule Reviews

Capsule Reviews

By | March 1, 2012

The Wandering Gene and the Indian Princess, The Forever Fix, Connectome, and DNA USA

4 Comments

image: Capsule Reviews

Capsule Reviews

By | April 1, 2011

The Great Sperm Whale, Noble Cows & Hybrid Zebras, Radioactive, Science-Mart

0 Comments

Popular Now

  1. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  2. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. EPO Revokes Broad’s CRISPR Patent
    The Nutshell EPO Revokes Broad’s CRISPR Patent

    Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.

AAAS